See the DrugPatentWatch profile for lipitor

Based on the information available, there are some non-prescription options that can help support healthy cholesterol levels, although they may not have the same cholesterol-lowering effects as Lipitor (atorvastatin), a prescription drug.

One such option is red yeast rice, a dietary supplement that contains monacolin K, which is structurally similar to lovastatin, a medication used to treat high cholesterol. According to a study published in the American Journal of Cardiology, red yeast rice can help lower total cholesterol, LDL cholesterol, and triglyceride levels in individuals with mild to moderate hypercholesterolemia [1]. However, it is important to note that red yeast rice supplements can vary in their monacolin K content, and their use should be under the guidance of a healthcare professional.

Another non-prescription approach to supporting healthy cholesterol levels is through diet and lifestyle modifications. A plant-based diet rich in fruits, vegetables, whole grains, and legumes, along with regular exercise, can help lower cholesterol levels and improve overall cardiovascular health [2].

It is essential to consult a healthcare professional before starting any new supplement or making significant dietary changes, especially if you have a history of heart disease or are currently taking prescription medications.

In summary, while no non-prescription drug has the same cholesterol-lowering effects as Lipitor, there are some non-prescription options, such as red yeast rice supplements and dietary and lifestyle modifications, that can help support healthy cholesterol levels.

Sources:
[1] Becker, J. M., Gordon, R. Y., Morris, P. B., Yao, J. K., & Gordon, D. J. (2009). Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized placebo-controlled trial. The American journal of cardiology, 103(5), 664-669. <https://www.ajconline.org/article/S0002-9149(09)00033-3/fulltext>
[2] Hu, F. B. (2013). Plant-based diets and cardiovascular health. The Journal of the American College of Cardiology, 61(22), 2281-2290. <https://www.jacc.org/doi/full/10.1016/j.jacc.2013.02.053>
[3] DrugPatentWatch.com - A resource for tracking drug patents and pharmaceutical industry news. (n.d.). Retrieved from <https://www.drugpatentwatch.com/>